Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitric oxide synthase 2 pseudogene 2 (NOS2P2) is a pseudogene related to the gene encoding inducible nitric oxide synthase (NOS2, iNOS). Pseudogenes typically arise due to duplication or mutation of functional genes and are generally not translated into functional proteins. While some pseudogenes have emerging roles in regulating gene expression via antisense RNA or truncated dominant-negative proteins, NOS2P2 is not known to encode a functional protein, nor is it considered a therapeutic target or disease biomarker. NOS2P2 may be referenced in genetics research due to its relationship to NOS2. The canonical functional target in clinical and drug development contexts is nitric oxide synthase, inducible (NOS2/iNOS).
None for NOS2P2, as it is a pseudogene and not a drug target. Mechanisms for NOS2 inhibitors (e.g., reduced NO production) do not apply.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric oxide synthase 2 pseudogene 2 (NOS2P2).